Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of Q fever. 26
Successful host cell infection requires the Coxiella Type IVB Secretion System (T4BSS), which 27 translocates bacterial effector proteins across the vacuole membrane into the host cytoplasm, 28
where they manipulate a variety of cell processes. To identify host cell targets of Coxiella 29 T4BSS effector proteins, we determined the transcriptome of murine alveolar macrophages 30 infected with a Coxiella T4BSS effector mutant. We identified a set of inflammatory genes that 31 are significantly upregulated in T4BSS mutant-infected cells compared to mock-infected cells or 32 cells infected with wild type (WT) bacteria, suggesting Coxiella T4BSS effector proteins 33 downregulate expression of these genes. In addition, the IL-17 signaling pathway was identified 34 as one of the top pathways affected by the bacteria. While previous studies demonstrated that 17 plays a protective role against several pathogens, the role of IL-17 during Coxiella infection is 36 unknown. We found that IL-17 kills intracellular Coxiella in a dose-dependent manner, with the 37 T4BSS mutant exhibiting significantly more sensitivity to IL-17 than WT bacteria. In addition, 38 quantitative PCR confirmed increased expression of IL-17 downstream signaling genes in 39 T4BSS mutant-infected cells compared to WT or mock-infected cells, including the pro-40 inflammatory cytokines I11a, Il1b and Tnfa, the chemokines Cxcl2 and Ccl5, and the 41 antimicrobial protein Lcn2. We further confirmed that the Coxiella T4BSS downregulates 42 macrophage CXCL2/MIP-2 and CCL5/RANTES protein levels following IL-17 stimulation. 43
Together, these data suggest that Coxiella downregulates IL-17 signaling in a T4BSS-dependent 44 manner in order to escape the macrophage immune response. 45
46

INTRODUCTION 48
The intracellular bacterium Coxiella burnetii is the etiological agent of Q fever, a 49 zoonotic infectious disease. Initially, Q fever manifests as an acute self-limited flu-like illness. 50
However, patients can develop chronic disease that can be life threatening due to serious clinical 51 manifestations such as endocarditis (1). Furthermore, the current therapy recommended for 52 chronic Q fever requires at least 18 months of doxycycline and hydroxychloroquine treatment 53 (2). An effective vaccine (Q-Vax) has been developed for humans but is currently licensed only 54
in Australia due to adverse effects, especially when administered in previously infected 55 populations (3). In addition, Q fever outbreaks have occurred in several countries, including the 56 Netherlands (4), US (5), Spain (6), Australia (7), Japan (8) and Israel (9), exemplifying how 57 expansive C. burnetii infection is worldwide and the need for novel therapeutic targets. 58
Human infection occurs primarily by inhaling contaminated dust or aerosols, often from 59 close contact with livestock. In the lungs, C. burnetii displays tropism for alveolar macrophages, 60
where it forms a phagolysosome-like parasitophorous vacuole (PV) necessary to support 61 bacterial growth (10, 11). C. burnetii's ability to survive and replicate inside the PV, an 62 inhospitable environment for most bacteria, is a unique feature essential for C. burnetii 63 pathogenesis. C. burnetii exploits the acidic PV pH for metabolic activation (12) and actively 64 manipulates PV fusogenicity and maintenance (13). PV establishment requires translocation of 65 bacterial proteins into the host cell cytoplasm by the C. burnetii Dot/Icm (defect in organelle 66 trafficking/intracellular multiplication) type IVB secretion system (T4BSS), closely related to the 67 Dot/Icm T4BSS of Legionella pneumophila (14) . T4BSS effector proteins not only manipulate 68 host vesicular trafficking during PV development, but also other cellular processes such as lipid 69 6 possible two-way comparisons revealed that the majority of DEGs were upregulated in icmD 116 mutant-infected compared to WT-infected cells (icmD vs. WT) (Fig. 1C) . In contrast, the 117 majority of DEGs were downregulated in WT-infected vs. mock-infected cells (WT vs. mock). 118
Overall there were fewer downregulated genes in the icmD mutant-infected cells vs. mock-119 infected cells (icmD vs. mock). This provides evidence that C. burnetii T4BSS effector proteins 120 may play a role in the downregulation of host cell genes during the initial stages of infection. 121
To identify biological pathways targeted by C. burnetii T4BSS effector proteins, we used 122 two methods: gene set enrichment via CERNO testing (30) using Gene Ontology (GO) 123 annotations as gene sets ( Supplementary Fig. 1 ) and the Ingenuity Pathways Analysis (IPA) 124 using DEGs with an absolute log 2 fold-change > 0.585 and FDR < 5% as input ( Fig. 2 ). Given that IL-17 is known to be an important 136 pro-inflammatory cytokine against several pulmonary pathogens, we specifically tested for 137 differential expression of IL-17 related genes (32) using self-contained gene set testing. The IL-138 7 17 gene set was overexpressed in icmD mutant-infected macrophages relative to WT-infected 139 macrophages (Supplementary Table 1 Between the WT and dotA mutant-infected macrophages, we observed a significant difference in 149 gene expression of the pro-inflammatory genes Il1a, Il1b and Tnfa ( Fig. 2A-C) as well as the IL-150 17 signaling pathway chemokines Cxcl2/Mip2 and Ccl5/Rantes (Fig. 2D-E ) and the 151 antimicrobial protein Lipocalin-2 (Lcn2) (Fig. 2F) . These genes were upregulated in the dotA 152 mutant-infected macrophages compared to WT-infected macrophages, with more significant 153 differences at 24 hpi compared to 48 hpi. IL-17A itself was not differentially regulated in either 154 our RNAseq data or RT-qPCR (data not shown), which is not surprising given that macrophages 155 produce very little IL-17 (35). These data suggest that, during the early stages of macrophage 156 infection, the C. burnetii T4BSS may target the IL-17 pathway in order to downregulate 157 expression of several pro-inflammatory genes. and CCL5/RANTES at 24 or 48 hpi using ELISA. We observed a significant difference in 167 CXCL2/MIP-2 and CCL5/RANTES protein levels between the WT and dotA mutant-infected 168 macrophages, with a 3-fold increase of both cytokines in the dotA mutant-infected macrophages 169
( Fig. 3A-B) , confirming the gene expression data. While CXCL2/MIP-2 was significantly higher 170 at both 24 and 48 hpi, we only detected a difference in CCL5/RANTES expression at 24 hpi 171 (Fig. 3B) . 172 LCN2 expression is strongly induced by IL-17 and blocks catecholate-type siderophores 173 of gram-negative bacteria, preventing the bacteria from scavenging free iron required for 174 bacterial growth (36, 37). While Lcn2 gene expression was differentially regulated (Fig. 2F) , we 175 did not observe a significant difference in secreted LCN2 protein between the WT versus dotA 176 mutant-infected macrophages at either 24 or 48 hpi (Fig. 3C ). These conflicting data may be due 177 to post-translational regulation of LCN2 (38). However, our data does suggest that the C. 
Gene expression analysis 382
RNAseq differential gene expression (DGE) analysis was performed using the edgeR 383 package (version 3.16.5) in R (version 3.3.3). After filtering genes with low expression across a 384 majority of samples, trimmed mean of M values (TMM) normalization was applied to the 385 remaining 9400 genes. Expression data for these genes were converted to log counts-per-million 386 (logCPM) for data visualization with principal components analysis (PCA) plots. DGE analysis 387 was performed using the glmLRT function as 2-way comparisons between the three classes 388 using the following model matrix formula: ~0+Infection_Time where Infection_Time is 389 combined factor variable consisting of cell treatment and time point (six levels). The fold change 390 in gene expression was determined by comparing wild type or icmD mutant-infected to mock-391 infected cells or each other at either 24h or 48h (six different comparisons). Differential 392 expression of functional pathways was assessed by two methods using the list of differentially 393 expressed genes (DEGs) for each comparison: 1) gene enrichment analysis using CERNO testing 394 in the tmod package (version 0.31) (30) in R with Gene Ontology (GO, C5 in MSigDB (88)) 395 annotations as gene sets and all DEGs without cut-off criteria but ranked by ascending P values 396 and 2) Ingenuity Pathways Analysis (version 42012434) using DEGs with |log 2 FC|>0.585 (1.5 in 397 linear space) and FDR<5% as input. In addition, self-contained gene set testing for enrichment of 398 IL-17 related genes (32) was also performed using the roast. DGElist function in the edgeR 399 package and the following gene list: Ccl5, Il17rc, Lcn2, Traf6, Il17ra, Nfkb1, Nfkb2, Ccl2, and 400
Ccl3. 401 402
Quantitative gene expression by real time-PCR (qRT-PCR) 403
MH-S cells (2x10 5 cells per well of a 6-well plate) were mock-infected or infected with 404 WT or dotA mutant C. burnetii in 0.5 ml growth media for 2 hours at 37°C and 5% CO 2 , washed 405 extensively with PBS and incubated in 2 ml of growth media. Cells treated with LPS (100 ng/ml) 406 from Escherichia coli O111:B4 (Sigma, catalog # L4392) were used as a positive control. RNA 407 was isolated using the RNeasy Plus Mini Kit at 24 and 48 hpi, analyzed for quantity and 408 A260/280 ratio (Implen NanoPhotometer), and cDNA generated using Super Script III First-409 strand synthesis system kit (Invitrogen). 
